CJRB-101pembrolizumabhead and neck squamous cell carcinomamelanomaNSCLC
… observed, suggesting an immune-mediated antitumor mechanism of CJRB-101. A total of 42 patients were enrolled in the low-dose cohort (o…
1articles mentioning drugs
8drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CJRB-101 ×
CJRB-101
This drug is selected. Its supporting articles are shown below.